GSK, PLC
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Current-version rows · memo entries excluded from net amount
Last updated . These are the last published financial totals; newer source data is not included yet.
A current recipient-party breakdown has not been published. Financial totals remain available; older party percentages are not shown.
Loading 10 contributions with dates…
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under GSK, PLC.
Showing the last published contribution snapshot. Newer source data is not included yet.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for GSK plc. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people · 10 per page
Showing 1–10 of 499 · largest absolute amount first
Reported name + ZIP cluster; not a verified identity merge · PHILADELPHIA, PA, 19112 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · PRESIDENT, US · 38 transaction rows
Reported name + ZIP cluster; not a verified identity merge · DURHAM, NC, 27709 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · VICE PRESIDENT, RESPIRATORY SALES · 38 transaction rows
Evidence-based cluster of 2 reported identities; not a verified identity merge · SCOTCH PLAINS, NJ, 07076 · GSK · Healthcare & Pharmaceuticals · DRUG DEVELOPMENT · Reported as GUIDI, JOSEPH / GUIDI, JOSEPH M. · 39 transaction rows
Evidence-based cluster of 2 reported identities; not a verified identity merge · WASHINGTON, DC, 20004 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · PUBLIC POLICY · 32 transaction rows
Reported name + ZIP cluster; not a verified identity merge · YOUNGSVILLE, NC, 27596 · GSK · Healthcare & Pharmaceuticals · DIRECTOR, SOLUTIONS DELIVERY · 1 transaction rows
Reported name + ZIP cluster; not a verified identity merge · WASHINGTON, DC, 20009 · GSK · Healthcare & Pharmaceuticals · STATISTICS LEADER · 2 transaction rows
Reported name + ZIP cluster; not a verified identity merge · WASHINGTON, DC, 20004 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · GOVERNMENT RELATIONS · 19 transaction rows
Reported name + ZIP cluster; not a verified identity merge · WASHINGTON, DC, 20004 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · ASSISTANT GENERAL COUNSEL · 36 transaction rows
Reported name + ZIP cluster; not a verified identity merge · DURHAM, NC, 27709 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · RX ACCOUNT MANAGEMENT ONCOLOGY · 34 transaction rows
Reported name + ZIP cluster; not a verified identity merge · COLLEGEVILLE, PA, 19426 · GLAXOSMITHKLINE LLC · Healthcare & Pharmaceuticals · VP, GLOBAL PRICING & MARKET ACCESS HEA · 34 transaction rows
Where the contributions went · 10 per page
Showing 1–10 of 68 · largest absolute amount first
PAC (qualified) · WASHINGTON, DC · 5,192 transaction rows
PAC (not qualified) · RALEIGH, NC · 20 transaction rows
Party committee (qualified) · WASHINGTON, DC · 37 transaction rows
PAC (qualified) · WASHINGTON, DC · 1 transaction rows
House campaign committee · ARLINGTON, VA · MCCLURE, ADELE · U.S. House VA 07 · 2 transaction rows
House campaign committee · MOUNTAINSIDE, NJ · ROTH, MICHAEL · U.S. House NJ 07 · 6 transaction rows
Senate campaign committee · AUSTIN, TX · TALARICO, JAMES · U.S. Senate TX 00 · 30 transaction rows
Senate campaign committee · OVERLAND PARK, KS · PARELKAR, LOIS ANNE ELIZABETH LEA · U.S. Senate KS 00 · 4 transaction rows
Party committee (qualified) · WASHINGTON, DC · 15 transaction rows
PAC with non-contribution account · CHEYENNE, WY · 5 transaction rows
Individual transactions · 10 per page
Dates below are the FEC-reported contribution dates, not filing or import dates. These are individual contributions grouped by the reported employer field, not contributions by a company.
Showing the last published contribution records; newer source data is not included yet.
Largest contribution amounts first. Select Date of contribution or Amount to reverse the order.
| Date of contribution ↕ | Amount ↓ | Reported contributor / location | Recipient / filing |
|---|---|---|---|
| 2025-08-01FEC filing ↗ | $250 | PAUL, ELAINERALEIGHNC27613SCIENTISTGSK | COOPER VICTORY FUNDC00913574Primary (P)* EARMARKED CONTRIBUTION THROUGH ACTBLUE ON 08/03/2025Filing 1956706 · amended |
| 2025-08-02FEC filing ↗ | $250 | HALLYBURTON, ELIZABETHDURHAMNC27705ATTORNEYGSK | ACTBLUEC00401224Not reportedEARMARKED FOR COOPER FOR NORTH CAROLINA (C00913566)Filing 1953256 · amended |
| 2025-08-02FEC filing ↗ | $250 | HALLYBURTON, ELIZABETHDURHAMNC27705ATTORNEYGLAXOSMITHKLINE | COOPER FOR NORTH CAROLINAC00913566Primary 2026 (P2026)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1956691 · amended |
| 2025-08-09FEC filing ↗ | $250 | FRANKE, JOANIEPOTTSTOWNPA19465FINANCEGSK | ACTBLUEC00401224Not reportedEARMARKED FOR CHRIS DELUZIO FOR CONGRESS (C00787648)Filing 1953256 · amended |
| 2025-08-14FEC filing ↗ | $250 | GUIDI, JOSEPHSCOTCH PLAINSNJ07076DRUG DEVELOPMENTGSK | DSCCC00042366Primary (P)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1916031 |
| 2025-08-14FEC filing ↗ | $250 | GUIDI, JOSEPHSCOTCH PLAINSNJ07076DRUG DEVELOPMENTGSK | ACTBLUEC00401224Not reportedEARMARKED FOR DSCC (C00042366)Filing 1953256 · amended |
| 2025-08-27FEC filing ↗ | $250 | ROSS, ABBYRALEIGHNC27605DIGITAL COMMUNICATIONSGSK | ACTBLUEC00401224Not reportedEARMARKED FOR COOPER VICTORY FUND (C00913574)Filing 1953256 · amended |
| 2025-08-27FEC filing ↗ | $250 | ROSS, ABBYRALEIGHNC27605DIGITAL COMMUNICATIONSGSK | COOPER VICTORY FUNDC00913574Primary (P)* EARMARKED CONTRIBUTION THROUGH ACTBLUE ON 08/31/2025Filing 1956706 · amended |
| 2025-06-09FEC filing ↗ | $250 | GUIDI, JOSEPHSCOTCH PLAINSNJ07076DRUG DEVELOPMENTGSK | MURPHY MOBILIZATION FUNDC00904417Primary (P)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1902748 |
| 2025-06-09FEC filing ↗ | $250 | GUIDI, JOSEPHSCOTCH PLAINSNJ07076DRUG DEVELOPMENTGSK | ACTBLUEC00401224Not reportedEARMARKED FOR MURPHY MOBILIZATION FUND (C00904417)Filing 1909062 |
Refunds remain negative. Memo-only rows are marked and are not additional money. Rows come from the latest available contribution publication.
Open full contribution table →Reported as GSK, PLC
Industry classification summary
GlaxoSmithKline plc rebranded to GSK plc in 2022 and is a multinational biopharmaceutical company specializing in medicines and vaccines.
AI classification auto-approved under admin authorization
View source